Suggest an Edit

You're suggesting changes to Japanese government panel endorses Sumitomo Pharma’s iPS-derived treatment for Parkinson’s (Event).

Only fields you change will be sent for review. Leave the rest alone.

Proposed Changes

Event Title

Current: Japanese government panel endorses Sumitomo Pharma’s iPS-derived treatment for Parkinson’s

Description

Current: TOKYO, Feb 19 (Reuters) - Japan's health ministry said on Thursday a panel of specialists had endorsed Sumitomo Pharma's iPS cell-derived treatment fo...

Venue Name

Current: Japanese government panel endorses Sumitomo Pharma’s iPS-derived treatment for Parkinson’s

Venue Address

Event URL

Additional Notes

Context for your edit (Optional)

Your Email *

Only used if we need to follow up about your suggestion. Never shared or published.

Security Verification

Cancel

By submitting, you agree to our Terms and Privacy Policy. Suggestions are reviewed by our team before any changes go live.